Loading...
Loading...
India's cyclosporine imports from UNITED STATES total $2.0M across 78 shipments from 15 foreign suppliers. ABBVIE LOGISTICS B.V leads with $751.2K in import value; the top 5 suppliers together control 85.7% of this origin. Leading Indian buyers include ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for cyclosporine — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ABBVIE LOGISTICS B.V is the leading Cyclosporine supplier from UNITED STATES to India, with import value of $751.2K across 12 shipments. The top 5 suppliers — ABBVIE LOGISTICS B.V, ALLERGAN PHARMACEUTICALS INTERNATIONAL, ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, AMSTERDAM PHARMA (APTEKA RX INC), ASAMAN — collectively account for 85.7% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ABBVIE LOGISTICS B.V | $751.2K | 12 | 38.3% |
| 2 | ALLERGAN PHARMACEUTICALS INTERNATIONAL | $585.8K | 5 | 29.9% |
| 3 | ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED | $205.8K | 3 | 10.5% |
| 4 | AMSTERDAM PHARMA (APTEKA RX INC) | $94.4K | 1 | 4.8% |
| 5 | ASAMAN | $44.0K | 2 | 2.2% |
| 6 | ASAMAN,INC. | $43.5K | 1 | 2.2% |
| 7 | Pharmaceutical Buyers, Inc. | $28.2K | 1 | 1.4% |
| 8 | ESPEE BIOPHARMA & FINECHEM LLC | $27.3K | 3 | 1.4% |
| 9 | RAFF & HALL PHARMACY | $26.2K | 7 | 1.3% |
| 10 | AGRACE PHARMA | $24.8K | 7 | 1.3% |
| 11 | RAFF HALL PHARMACY | $23.1K | 2 | 1.2% |
| 12 | Asaman, Inc. | $20.3K | 1 | 1.0% |
| 13 | Asaman Inc | $20.1K | 1 | 1.0% |
| 14 | M/S SUN PHARMACEUTICAL INDUSTRIES INC | $18.3K | 2 | 0.9% |
| 15 | Regional Pharmacy | $14.2K | 1 | 0.7% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED | $751.2K | 12 | 38.3% |
| 2 | ALLERGAN INDIA PRIVATE LIMITED | $585.8K | 5 | 29.9% |
| 3 | ALLERGAN INDIA PRIVATE LTD | $205.8K | 3 | 10.5% |
| 4 | MYLAN LABORATORIES LIMITED | $156.3K | 7 | 8.0% |
| 5 | HETERO LABS LIMITED | $107.7K | 6 | 5.5% |
| 6 | MICRO LABS LIMITED | $52.4K | 8 | 2.7% |
| 7 | LUPIN LIMITED | $26.7K | 1 | 1.4% |
| 8 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $18.3K | 2 | 0.9% |
| 9 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI | $14.2K | 1 | 0.7% |
| 10 | AUROBINDO PHARMA LIMITED | $12.4K | 5 | 0.6% |
| 11 | MANKIND PHARMA LIMITED | $11.5K | 1 | 0.6% |
| 12 | RUBICON RESEARCH LIMITED | $4.7K | 2 | 0.2% |
| 13 | CLIANTHA RESEARCH LIMITED | $4.1K | 5 | 0.2% |
| 14 | AUROBINDO PHARMA LTD | $3.5K | 3 | 0.2% |
| 15 | STRIDES PHARMA SCIENCE LIMITED | $3.1K | 3 | 0.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Cyclosporine suppliers from UNITED STATES to India include ABBVIE LOGISTICS B.V, ALLERGAN PHARMACEUTICALS INTERNATIONAL, ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED. The leading supplier is ABBVIE LOGISTICS B.V with import value of $751.2K USD across 12 shipments. India imported Cyclosporine worth $2.0M USD from UNITED STATES in total across 78 shipments.
India imported Cyclosporine worth $2.0M USD from UNITED STATES across 78 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Cyclosporine sourced from UNITED STATES include ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED, ALLERGAN INDIA PRIVATE LIMITED, ALLERGAN INDIA PRIVATE LTD. The largest buyer is ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED with $751.2K in imports across 12 shipments.
The total value of Cyclosporine imports from UNITED STATES to India is $2.0M USD, across 78 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
78 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists